NNovo Nordisk Read More Lilly Stock Near A High: What Can Democrats Change?2026-11-03 For questions about this article or underlying research, email help@trefis.com. Part of our midterms guide. Start here: what…
NNovo Nordisk Read More Where Will Novo Stock Be in 10 Years?2026-10-21 Key Points Novo remains a leader in the diabetes and weight loss drug markets. The company could make…
NNovo Nordisk Read More Forget Eli Lilly and Novo: This Biotech Could Be a Surprising Winner in the Weight Loss Market2026-10-19 Key Points Regeneron’s leading weight-loss candidate could offer patients an option with fewer side effects. The company has…
NNovo Nordisk Read More 4 Healthcare Stocks Worth Owning for the Next Decade2026-10-12 Key Points Healthcare is an industry known for research and development, with the most innovative companies often becoming…
NNovo Nordisk Read More UBS Called Novo Nordisk a ‘Value Trap.’ Here’s the Other Side of That Argument.2026-10-12 Key Points UBS analyst Michael Yee believes investors prefer Eli Lilly’s growth story to Novo Nordisk’s turnaround story.…
NNovo Nordisk Read More Better High-Yield Dividend Stock: Pfizer or Novo Nordisk?2026-10-06 Key Points Novo Nordisk is a leading GLP-1 company, but its portfolio beyond that is limited. Pfizer hasn’t…
NNovo Nordisk Read More Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buy2026-10-01 Key Points Novo Nordisk could strengthen its obesity pipeline by buying out Kailera Therapeutics and Viking Therapeutics. These…
NNovo Nordisk Read More Could This Be Novo Nordisk’s Next Billion-Dollar Weight-Loss Product?2026-09-27 Key Points Novo Nordisk needs new products to better compete with Eli Lilly in the weight loss market.…
NNovo Nordisk Read More Why Is NVO Stock Sliding Premarket Today?2026-09-21 Novo Nordisk’s long-term growth targets failed to ease investor concerns over Eli Lilly’s obesity-drug lead, CagriSema’s comparative performance…
NNovo Nordisk Read More Where Will Novo Nordisk Be in 5 Years as the GLP-1 Market Gets More Crowded?2026-09-16 Key Points Novo Nordisk has lost its lead in the weight loss market. The company could face even…
NNovo Nordisk Read More Could This New Opportunity Be Worth Billions for Novo Nordisk?2026-09-11 Key Points A recent clinical trial win could help Novo Nordisk expand its GLP-1 addressable market. The company…
NNovo Nordisk Read More Could This New Opportunity Be Worth Billions for Novo Nordisk?2026-09-11 Key Points A recent clinical trial win could help Novo Nordisk expand its GLP-1 addressable market. The company…